Outset Medical IncNASDAQ:OMNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.6076
- TODAY'S CHANGE (%)0.0236 (4.0504%)
- Bid / Lots0.6051/ 3
- Ask / Lots0.6100/ 10
- Open / Previous Close0.5800 / 0.5839
- Day Range
- 52 Week Range
- Volume239,856
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | OM |
|---|---|---|
| 09:32 ET | 2872 | 0.585 |
| 09:34 ET | 178 | 0.6 |
| 09:36 ET | 15964 | 0.6 |
| 09:41 ET | 170 | 0.589 |
| 09:43 ET | 100 | 0.586 |
| 09:45 ET | 300 | 0.589 |
| 09:50 ET | 100 | 0.586 |
| 09:52 ET | 100 | 0.586 |
| 09:54 ET | 200 | 0.586 |
| 09:56 ET | 100 | 0.586 |
| 09:57 ET | 500 | 0.59155 |
| 09:59 ET | 200 | 0.586101 |
| 10:01 ET | 11847 | 0.5861 |
| 10:03 ET | 8380 | 0.58 |
| 10:06 ET | 100 | 0.58 |
| 10:08 ET | 100 | 0.58 |
| 10:10 ET | 200 | 0.58 |
| 10:12 ET | 2175 | 0.5801 |
| 10:14 ET | 16246 | 0.58 |
| 10:15 ET | 9300 | 0.58 |
| 10:17 ET | 500 | 0.5804 |
| 10:19 ET | 12177 | 0.57 |
| 10:21 ET | 2100 | 0.57 |
| 10:24 ET | 1591 | 0.57 |
| 10:26 ET | 1100 | 0.571 |
| 10:28 ET | 100 | 0.571 |
| 10:30 ET | 100 | 0.5711 |
| 10:32 ET | 1250 | 0.57265 |
| 10:33 ET | 2850 | 0.57 |
| 10:35 ET | 500 | 0.5741 |
| 10:37 ET | 2212 | 0.5697 |
| 10:42 ET | 1611 | 0.57 |
| 10:44 ET | 21015 | 0.574 |
| 10:46 ET | 1987 | 0.5797 |
| 10:48 ET | 500 | 0.5741 |
| 10:50 ET | 300 | 0.5772 |
| 10:51 ET | 300 | 0.5796 |
| 10:53 ET | 2299 | 0.5795 |
| 10:55 ET | 1136 | 0.5826 |
| 10:57 ET | 200 | 0.5826 |
| 11:00 ET | 500 | 0.5826 |
| 11:02 ET | 200 | 0.5826 |
| 11:04 ET | 200 | 0.5805 |
| 11:06 ET | 100 | 0.5795 |
| 11:08 ET | 500 | 0.5795 |
| 11:09 ET | 289 | 0.5795 |
| 11:15 ET | 7400 | 0.5807 |
| 11:18 ET | 5682 | 0.5857 |
| 11:20 ET | 500 | 0.5914 |
| 11:22 ET | 300 | 0.5914 |
| 11:24 ET | 400 | 0.5914 |
| 11:26 ET | 100 | 0.5914 |
| 11:27 ET | 6200 | 0.5857 |
| 11:29 ET | 1000 | 0.5914 |
| 11:31 ET | 16116 | 0.5857 |
| 11:36 ET | 200 | 0.5857 |
| 11:38 ET | 901 | 0.58975 |
| 11:40 ET | 1200 | 0.59185 |
| 11:42 ET | 300 | 0.59185 |
| 11:44 ET | 200 | 0.59185 |
| 11:45 ET | 600 | 0.59 |
| 11:47 ET | 994 | 0.59 |
| 11:49 ET | 200 | 0.5857 |
| 11:51 ET | 100 | 0.5887 |
| 11:54 ET | 3300 | 0.5887 |
| 11:56 ET | 300 | 0.5887 |
| 11:58 ET | 793 | 0.5887 |
| 12:03 ET | 1100 | 0.5857 |
| 12:07 ET | 1231 | 0.5917 |
| 12:09 ET | 600 | 0.5857 |
| 12:12 ET | 400 | 0.5857 |
| 12:14 ET | 268 | 0.5917 |
| 12:18 ET | 700 | 0.5857 |
| 12:25 ET | 100 | 0.5857 |
| 12:27 ET | 5782 | 0.5857 |
| 12:32 ET | 100 | 0.5857 |
| 12:34 ET | 867 | 0.588915 |
| 12:36 ET | 20153 | 0.5918 |
| 12:38 ET | 1200 | 0.5914 |
| 12:39 ET | 1200 | 0.5914 |
| 12:41 ET | 2436 | 0.5982 |
| 12:43 ET | 2158 | 0.59845 |
| 12:45 ET | 467 | 0.59845 |
| 12:48 ET | 200 | 0.597 |
| 12:50 ET | 600 | 0.597 |
| 12:52 ET | 600 | 0.5985 |
| 12:54 ET | 600 | 0.59845 |
| 12:56 ET | 3563 | 0.6 |
| 12:57 ET | 800 | 0.6097 |
| 12:59 ET | 1150 | 0.604 |
| 01:01 ET | 500 | 0.6096 |
| 01:03 ET | 364 | 0.608 |
| 01:06 ET | 300 | 0.60485 |
| 01:08 ET | 600 | 0.6001 |
| 01:14 ET | 2100 | 0.6005 |
| 01:15 ET | 1099 | 0.605 |
| 01:17 ET | 531 | 0.6073 |
| 01:19 ET | 1200 | 0.6052 |
| 01:21 ET | 415 | 0.6051 |
| 01:24 ET | 1917 | 0.6073 |
| 01:26 ET | 779 | 0.605 |
| 01:28 ET | 400 | 0.6097 |
| 01:30 ET | 500 | 0.6052 |
| 01:32 ET | 700 | 0.6053 |
| 01:33 ET | 200 | 0.6075 |
| 01:37 ET | 2743 | 0.6097 |
| 01:39 ET | 200 | 0.60755 |
Today
Outset Medical Inc Is Being Sued For Possible Securities Fraud And Affected Shareholders Are Urged To Contact The Schall Law Firm, from 2 hours ago by Dow Jones
2 hours ago by Dow JonesOutset Medical (OM) Receives Nasdaq Notice, Shares No Longer Meet Minimum Bid Requirement, Class Action Pending After FDA Warning - Hagens Berman, from 5 hours ago by Dow Jones
5 hours ago by Dow Jones
Yesterday
ROSEN, A TOP RANKED LAW FIRM, Encourages Outset Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action -- OM, from 20 hours ago by Dow Jones
20 hours ago by Dow JonesOutset Medical (OM) Receives Nasdaq Notice, Shares No Longer Meet Minimum Bid Requirement, Class Action Pending After FDA Warning - Hagens Berman, from 12:40PM ET on Thursday Oct 03, 2024 by Dow Jones
12:40PM ET on Thursday Oct 03, 2024 by Dow JonesThe Schall Law Firm Encourages Investor Participation In A Case Against Outset Medical, Inc. For Securities Law Violations, from 11:02AM ET on Thursday Oct 03, 2024 by Dow Jones
11:02AM ET on Thursday Oct 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Outset Medical Inc | 30.4M | -0.2x | --- |
Harvard Bioscience Inc | 107.3M | -9.9x | --- |
ViewRay Inc | 180.0 | 0.0x | --- |
Fonar Corp | 106.7M | 11.1x | -7.15% |
Xylo Technologies Ltd | 2.2M | -0.1x | --- |
Akoya Biosciences Inc | 126.5M | -2.3x | --- |
Company Information
Outset Medical, Inc. is a medical technology company. The Company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The Company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by virtually anyone. The Tablo system comprises components, which include Tablo Console, Tablo Cartridge and Tablo Data Ecosystem. Tablo Console is a compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and touchscreen interface with 3D animations. It also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.
Contact Information
- Headquarters
- 3052 Orchard DriveSAN JOSE, CA, United States 95134
- Phone
- 971-563-3083
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer
- Leslie Trigg
- Chief Financial Officer
- Nabeel Ahmed
- Senior Vice President - Operations and R&D
- Marc Nash
- General Counsel, Company Secretary
- John Brottem
- Lead Independent Director
- D. Keith Grossman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $30.4M |
|---|---|
Revenue (TTM) | $116.4M |
Shares Outstanding | 52.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.94 |
EPS | $-3.14 |
Book Value | $2.44 |
P/E Ratio | -0.2x |
Price/Sales (TTM) | 0.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -129.25% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
